Discovery of novel ATAD2 bromodomain inhibitors that trigger apoptosis and autophagy in breast cells by structure-based virtual screening
ATAD2 has been reported to play an important role in the processes of numerous cancers and validated to be a potential therapeutic target. This work is to discover potent ATAD2 inhibitors and elucidate the underlying mechanisms in breast cancer. A novel ATAD2 bromodomain inhibitor (AM879) was discov...
Saved in:
Main Authors: | Dahong Yao (Author), Jin Zhang (Author), Jinhui Wang (Author), Dabo Pan (Author), Zhendan He (Author) |
---|---|
Format: | Book |
Published: |
Taylor & Francis Group,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fragment-based design, synthesis and biological evaluation of theophylline derivatives as ATAD2 inhibitors in BT-549 cells
by: Dahong Yao, et al.
Published: (2023) -
Design, synthesis and biological evaluation of novel tetrahydrothieno [2,3-c]pyridine substitued benzoyl thiourea derivatives as PAK1 inhibitors in triple negative breast cancer
by: Dahong Yao, et al.
Published: (2020) -
Discovery of a small molecule inhibitor of cullin neddylation that triggers ER stress to induce autophagy
by: Yanan Li, et al.
Published: (2021) -
Discovery of Tyrosinase Inhibitors: Structure-Based Virtual Screening and Biological Evaluation
by: Guan Wang, et al.
Published: (2022) -
Discovery of the natural product 3',4',7,8-tetrahydroxyflavone as a novel and potent selective BRD4 bromodomain 2 inhibitor
by: Jiao Li, et al.
Published: (2021)